November 10, 2025

SPT Labtech and 10x Genomics Partner to Automate Single Cell Workflows

SPT Labtech and 10x Genomics Partner to Automate Single Cell Workflows

Melbourn, UK, and Pleasanton, California, US, 14 October 2025: SPT Labtech, a pioneer in the design and development of laboratory automation and liquid handling solutions, and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a strategic partnership to provide automated workflows for single cell research. The collaboration will allow scientists to scale experiments on 10x’s Chromium Single Cell platform, with planned future expansion to the Visium Spatial platform, by providing plug-and-play protocols on SPT Labtech’s firefly® liquid handling platform.

Through this collaboration, firefly® users will gain access to optimized, ready-to-run methods developed with combined expertise from both companies’ application teams. These protocols are designed to streamline single cell assay workflows, and improve reproducibility, efficiency, and scalability. This partnership builds on 10x’s acquisition of Scale Biosciences, a company already partnered with SPT Labtech. Many firefly® users rely on Scale Biosciences chemistries, and this expanded collaboration with 10x will provide researchers access to the company’s full range of single cell and spatial solutions.

The partnership will be spotlighted at the American Society of Human Genetics (ASHG) conference, where data from customer labs, demonstrating how automated liquid handling streamlines single-cell library prep workflows, will be presented. Development of the methods has been informed by application work conducted in customer labs with the preparation workflow addressing one of the biggest challenges in single-cell transcriptomics: scalability.

Morten Frost, Chief Commercial Officer at SPT Labtech, said: “Single cell experiments are a critical area of focus for our firefly community. Working closely with 10x Genomics has been key to understanding the specific challenges and needs of researchers in this space. By making these optimized methods available in the firefly cloud, we are empowering scientists with easier access to cutting-edge tools for single cell discovery, while reducing barriers to adoption of advanced workflows.”

Brooke Murphy, Vice President, Strategic Marketing at 10x Genomics, added:“10x Genomics is committed to enabling researchers everywhere to uncover new insights into biology through our single cell solutions. This partnership with SPT Labtech will allow more labs to seamlessly automate their workflows, combining the flexibility of firefly automation with the robustness of our GEM-X chemistry, ultimately accelerating breakthroughs in human health.”

SPT Labtech and 10x Genomics will exhibit (booth 2487 and 947, respectively) at ASHG, 14th – 18th October, Boston, MA, where customer data and new workflows developed will be highlighted.

Media Contact: Dr Ben Rutter, Zyme Communications – ben.rutter@zymecommunications.com

Our latest News

discover more
AlphaFold Database adds viral protein complexes to support pandemic preparedness

AlphaFold Database adds viral protein complexes to support pandemic preparedness

by Sera Guli The latest release includes protein structure predictions for thousands of viruses, which could improve the response to future outbreaks AI-predicted protein complex structures for over 2,800 viruses are now openly available in the AlphaFold Database. To better understand and protect against emerging pathogens, the dataset prioritises proteomes from viral families known to […]

European Commission grants €57 million to critical open data resources

European Commission grants €57 million to critical open data resources

Horizon Europe funding will support GENCODE, UniProt, and Europe PMC The European Commission has announced €57 million in funding to support GENCODE, UniProt, and Europe PMC. These life sciences data resources are delivered and managed by EMBL’s European Bioinformatics Institute (EMBL-EBI) alongside international partners. The financial support will be given in the shape of three […]

Harnessing Synthetic Cellular Systems as Immune Cell Boosters

Harnessing Synthetic Cellular Systems as Immune Cell Boosters

How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Max Planck Institute for Medical Research and the Fraunhofer Institute for Cell Therapy and Immunology IZI are collaborating on new research approaches to advance the development of cell-based immunotherapies. The […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp